EP2569633
COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.5.2011EP published:
10.2.2016EP application number:
11781409.5
EPO information:
European Patent Register
Max expiry date:
15.5.2031
Title:
COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
Timeline
Today
16.5.2011EP application
10.2.2016EP Publication
Owner
Name:
The General Hospital CorporationAddress:
55 Fruit Street, 02114, Boston, MA, US
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Inventor
Name:
HACOHEN, NirAddress:
BrooklineMA, US
Name:
WU, CatherineAddress:
BrooklineMA, US
Priority
Number:
334866 PDate:
14.5.2010Country:
US
Classification
Categories:
G01N 33/53, G01N 33/68, A61K 39/395, A61P 35/00, C12Q 1/68, C07K 14/47, G01N 33/50, C07K 7/06